PBLS PARABILIS MEDICINES INC More: the full row for PARABILIS MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 4,615,612 shares; 2026Q3: 4,615,612 shares 4,615,612 $149M 10.01% 0 Timeline PRAX PRAXIS PRECISION MEDICINES I More: the full row for PRAXIS PRECISION MEDICINES I Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,693,219 shares; 2025Q1: 1,745,000 shares; 2025Q2: 1,625,000 shares; 2025Q3: 1,000,000 shares; 2025Q4: 950,000 shares; 2026Q1: 885,500 shares; 2026Q2: 640,000 shares; 2026Q3: 500,000 shares 500,000 $146M 9.78% -140,000 Timeline RAPP RAPPORT THERAPEUTICS INC More: the full row for RAPPORT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,940,921 shares; 2025Q1: 2,940,921 shares; 2025Q2: 2,940,921 shares; 2025Q3: 3,192,521 shares; 2025Q4: 3,027,521 shares; 2026Q1: 2,957,521 shares; 2026Q2: 2,657,521 shares; 2026Q3: 2,457,521 shares 2,457,521 $82.6M 5.54% -200,000 Timeline EWTX EDGEWISE THERAPEUTICS INC More: the full row for EDGEWISE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,406,534 shares; 2025Q1: 4,101,992 shares; 2025Q2: 4,251,992 shares; 2025Q3: 4,010,000 shares; 2025Q4: 3,285,000 shares; 2026Q1: 3,260,000 shares; 2026Q2: 2,510,000 shares; 2026Q3: 1,860,000 shares 1,860,000 $75.5M 5.07% -650,000 Timeline BBOT BRIDGEBIO ONCOLOGY THERAPEUT More: the full row for BRIDGEBIO ONCOLOGY THERAPEUT Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 17,878,594 shares; 2025Q4: 17,878,594 shares; 2026Q1: 17,878,594 shares; 2026Q2: 17,878,594 shares; 2026Q3: 17,878,594 shares 17,878,594 $73.3M 4.92% 0 Timeline ERAS ERASCA INC More: the full row for ERASCA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 5,800,000 shares; 2026Q2: 6,000,000 shares; 2026Q3: 5,000,000 shares 5,000,000 $73.3M 4.92% -1,000,000 Timeline BLSM BLOSSOMHILL THERAPEUTICS INC More: the full row for BLOSSOMHILL THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 3,614,034 shares 3,614,034 $67.4M 4.52% new Timeline ANL ADLAI NORTYE GROUP LTD More: the full row for ADLAI NORTYE GROUP LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,897,857 shares; 2026Q2: 3,978,229 shares; 2026Q3: 3,978,229 shares 3,978,229 $63.7M 4.27% 0 Timeline DNTH DIANTHUS THERAPEUTICS INC More: the full row for DIANTHUS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 950,000 shares; 2026Q2: 750,000 shares; 2026Q3: 500,000 shares 500,000 $44M 2.96% -250,000 Timeline ABVX ABIVAX SA More: the full row for ABIVAX SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,130,000 shares; 2025Q1: 2,130,000 shares; 2025Q2: 2,130,000 shares; 2025Q3: 1,950,000 shares; 2025Q4: 1,350,000 shares; 2026Q1: 760,000 shares; 2026Q2: 675,000 shares; 2026Q3: 425,000 shares 425,000 $42.1M 2.83% -250,000 Timeline DRUG BRIGHT MINDS BIOSCIENCES INC More: the full row for BRIGHT MINDS BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,059,331 shares; 2025Q1: 1,059,331 shares; 2025Q2: 1,059,331 shares; 2025Q3: 1,059,331 shares; 2025Q4: 1,059,331 shares; 2026Q1: 1,059,331 shares; 2026Q2: 900,000 shares; 2026Q3: 800,000 shares 800,000 $39.9M 2.68% -100,000 Timeline ETRA ELECTRA THERAPEUTICS INC More: the full row for ELECTRA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 3,365,533 shares 3,365,533 $37.9M 2.54% new Timeline MLTX MOONLAKE IMMUNOTHERAPEUTICS More: the full row for MOONLAKE IMMUNOTHERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,494,151 shares; 2025Q1: 8,494,151 shares; 2025Q2: 8,494,151 shares; 2025Q3: 1,994,173 shares; 2025Q4: 4,355,433 shares; 2026Q1: 4,480,433 shares; 2026Q2: 3,205,433 shares; 2026Q3: 2,855,433 shares 2,855,433 $33.4M 2.24% -350,000 Timeline ORKA ORUKA THERAPEUTICS INC More: the full row for ORUKA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 533,340 shares; 2025Q4: 533,340 shares; 2026Q1: 533,340 shares; 2026Q2: 533,340 shares; 2026Q3: 400,000 shares 400,000 $33.3M 2.24% -133,340 Timeline ATTO ATTOVIA THERAPEUTICS INC More: the full row for ATTOVIA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,788,815 shares 1,788,815 $30.7M 2.06% new Timeline FTH FAETH THERAPEUTICS INC More: the full row for FAETH THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 306,222 shares; 2026Q2: 1,028,242 shares; 2026Q3: 1,028,242 shares 1,028,242 $30.6M 2.05% 0 Timeline LTGO LATIGO BIOTHERAPEUTICS INC More: the full row for LATIGO BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,815,740 shares 1,815,740 $30.3M 2.04% new Timeline AGMB AGOMAB THERAPEUTICS NV More: the full row for AGOMAB THERAPEUTICS NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,465,348 shares; 2026Q2: 2,465,348 shares; 2026Q3: 2,465,348 shares 2,465,348 $27.4M 1.84% 0 Timeline IRD OPUS GENETICS INC More: the full row for OPUS GENETICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 5,500,000 shares 5,500,000 $26.6M 1.79% new Timeline CLYM CLIMB BIO INC More: the full row for CLIMB BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,106,000 shares; 2026Q3: 2,106,000 shares 2,106,000 $24.2M 1.62% 0 Timeline FRNM FREENOME INC More: the full row for FREENOME INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,431,032 shares 1,431,032 $22.5M 1.51% new Timeline MBX MBX BIOSCIENCES INC More: the full row for MBX BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 700,000 shares; 2025Q1: 700,000 shares; 2025Q2: 700,000 shares; 2025Q3: 1,225,000 shares; 2025Q4: 1,120,000 shares; 2026Q1: 1,120,000 shares; 2026Q2: 550,000 shares; 2026Q3: 375,000 shares 375,000 $22M 1.48% -175,000 Timeline BHVN BIOHAVEN LTD More: the full row for BIOHAVEN LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 55,539 shares; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares; 2026Q1: 1,760,000 shares; 2026Q2: 2,610,000 shares; 2026Q3: 1,510,000 shares 1,510,000 $20.2M 1.35% -1,100,000 Timeline ADRX ADARX PHARMACEUTICALS INC More: the full row for ADARX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 962,898 shares 962,898 $19.2M 1.29% new Timeline EYPT EYEPOINT INC More: the full row for EYEPOINT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,325,000 shares; 2025Q1: 8,325,000 shares; 2025Q2: 8,325,000 shares; 2025Q3: 8,325,000 shares; 2025Q4: 8,265,000 shares; 2026Q1: 8,265,000 shares; 2026Q2: 7,000,000 shares; 2026Q3: 5,750,000 shares 5,750,000 $18.8M 1.26% -1,250,000 Timeline TNGX TANGO THERAPEUTICS INC More: the full row for TANGO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,425,000 shares; 2026Q2: 1,300,000 shares; 2026Q3: 700,000 shares 700,000 $17.5M 1.17% -600,000 Timeline DMRA DAMORA THERAPEUTICS INC More: the full row for DAMORA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 800,000 shares 800,000 $17M 1.14% new Timeline BBIO BRIDGEBIO PHARMA INC More: the full row for BRIDGEBIO PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,600,000 shares; 2025Q1: 2,000,000 shares; 2025Q2: 1,600,000 shares; 2025Q3: 1,400,000 shares; 2025Q4: 1,200,000 shares; 2026Q1: 850,000 shares; 2026Q2: 550,000 shares; 2026Q3: 250,000 shares 250,000 $16.4M 1.1% -300,000 Timeline CUE CUE BIOPHARMA INC More: the full row for CUE BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 625,285 shares 625,285 $16.2M 1.09% new Timeline CRBP CORBUS PHARMACEUTICALS HLDGS More: the full row for CORBUS PHARMACEUTICALS HLDGS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,375,000 shares; 2025Q1: 2,375,000 shares; 2025Q2: 2,375,000 shares; 2025Q3: 2,375,000 shares; 2025Q4: 2,344,971 shares; 2026Q1: 2,344,971 shares; 2026Q2: 2,344,971 shares; 2026Q3: 2,344,971 shares 2,344,971 $16M 1.07% 0 2026-10-31, 13G/A : 1,500,000 shares, 7.76% of the class, 13G/A filed 2026-11-02 Timeline BIOA BIOAGE LABS INC More: the full row for BIOAGE LABS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,629,529 shares; 2025Q1: 2,629,529 shares; 2025Q2: 2,140,605 shares; 2025Q3: 2,140,605 shares; 2025Q4: 2,040,605 shares; 2026Q1: 2,890,605 shares; 2026Q2: 2,390,605 shares; 2026Q3: 2,240,605 shares 2,240,605 $15.9M 1.07% -150,000 Timeline ALMS ALUMIS INC More: the full row for ALUMIS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,147,396 shares; 2025Q1: 2,147,396 shares; 2025Q2: 2,147,396 shares; 2025Q3: 2,147,396 shares; 2025Q4: 3,635,596 shares; 2026Q1: 3,949,241 shares; 2026Q2: 3,285,596 shares; 2026Q3: 2,075,000 shares 2,075,000 $15.3M 1.03% -1,210,596 Timeline OLMA OLEMA PHARMACEUTICALS INC More: the full row for OLEMA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,750,000 shares; 2026Q1: 3,900,000 shares; 2026Q2: 2,150,000 shares; 2026Q3: 1,750,000 shares 1,750,000 $15.1M 1.02% -400,000 Timeline PHVS PHARVARIS N V More: the full row for PHARVARIS N V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,466,460 shares; 2025Q1: 1,466,460 shares; 2025Q2: 1,454,660 shares; 2025Q3: 1,363,200 shares; 2025Q4: 1,083,000 shares; 2026Q1: 1,000,000 shares; 2026Q2: 750,000 shares; 2026Q3: 450,000 shares 450,000 $14.3M 0.96% -300,000 Timeline HLXC HELIX ACQUISITION CORP III More: the full row for HELIX ACQUISITION CORP III Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,297,500 shares; 2026Q2: 1,297,500 shares; 2026Q3: 1,297,500 shares 1,297,500 $13.8M 0.93% 0 Timeline SYRE SPYRE THERAPEUTICS INC More: the full row for SPYRE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 225,000 shares; 2026Q3: 125,000 shares 125,000 $11.1M 0.75% -100,000 Timeline DFTX DEFINIUM THERAPEUTICS INC More: the full row for DEFINIUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 400,000 shares; 2026Q3: 275,000 shares 275,000 $10.5M 0.7% -125,000 Timeline ACRS ACLARIS THERAPEUTICS INC More: the full row for ACLARIS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,750,000 shares 1,750,000 $9.21M 0.62% new Timeline AMLX AMYLYX PHARMACEUTICALS INC More: the full row for AMYLYX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 500,000 shares; 2025Q4: 400,000 shares; 2026Q1: 350,000 shares; 2026Q2: 200,000 shares; 2026Q3: 300,000 shares 300,000 $8.73M 0.59% +100,000 Timeline CABA CABALETTA BIO INC More: the full row for CABALETTA BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 5,000,000 shares; 2025Q3: 5,000,000 shares; 2025Q4: 4,400,000 shares; 2026Q1: 5,500,000 shares; 2026Q2: 5,000,000 shares; 2026Q3: 4,500,000 shares 4,500,000 $8.64M 0.58% -500,000 Timeline INBX INHIBRX BIOSCIENCES INC More: the full row for INHIBRX BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 50,000 shares 50,000 $5M 0.34% new Timeline KLRA KAILERA THERAPEUTICS INC More: the full row for KAILERA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 550,000 shares; 2026Q3: 400,000 shares 400,000 $4.57M 0.31% -150,000 Timeline JBIO JADE BIOSCIENCES INC More: the full row for JADE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000 $4.21M 0.28% new Timeline IBIO IBIO INC More: the full row for IBIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,570,000 shares; 2026Q3: 3,570,000 shares 3,570,000 $4.21M 0.28% 0 Timeline TARS TARSUS PHARMACEUTICALS INC More: the full row for TARSUS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 500,000 shares; 2025Q1: 400,000 shares; 2025Q2: 300,000 shares; 2025Q3: 300,000 shares; 2025Q4: 250,000 shares; 2026Q1: 225,000 shares; 2026Q2: 100,000 shares; 2026Q3: 50,000 shares 50,000 $3.93M 0.26% -50,000 Timeline ROIV ROIVANT SCIENCES LTD More: the full row for ROIVANT SCIENCES LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 750,000 shares; 2026Q2: 475,000 shares; 2026Q3: 100,000 shares 100,000 $3.66M 0.25% -375,000 Timeline ELVN ENLIVEN THERAPEUTICS INC More: the full row for ENLIVEN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 250,000 shares; 2025Q1: 250,000 shares; 2025Q2: 200,000 shares; 2025Q3: 200,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 150,000 shares; 2026Q3: 75,000 shares 75,000 $3.44M 0.23% -75,000 Timeline ASND ASCENDIS PHARMA A/S More: the full row for ASCENDIS PHARMA A/S Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 50,000 shares; 2026Q3: 15,000 shares 15,000 $3.42M 0.23% -35,000 Timeline ODTX ODYSSEY THERAPEUTICS INC More: the full row for ODYSSEY THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 175,000 shares; 2026Q3: 125,000 shares 125,000 $2.78M 0.19% -50,000 Timeline NAMS NEWAMSTERDAM PHARMA COMPANY More: the full row for NEWAMSTERDAM PHARMA COMPANY Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,250,000 shares; 2025Q1: 2,825,000 shares; 2025Q2: 2,175,000 shares; 2025Q3: 2,175,000 shares; 2025Q4: 1,000,000 shares; 2026Q1: 950,000 shares; 2026Q2: 500,000 shares; 2026Q3: 100,000 shares 100,000 $2.43M 0.16% -400,000 Timeline BOLD BOUNDLESS BIO INC More: the full row for BOUNDLESS BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,000,000 shares; 2026Q3: 940,000 shares 940,000 $2.36M 0.16% -60,000 Timeline INSM INSMED INC More: the full row for INSMED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 650,000 shares; 2025Q1: 525,000 shares; 2025Q2: 540,000 shares; 2025Q3: 430,000 shares; 2025Q4: 275,000 shares; 2026Q1: 190,000 shares; 2026Q2: 75,000 shares; 2026Q3: 20,000 shares 20,000 $2.28M 0.15% -55,000 Timeline BRVE BRAVEHEART BIO INC More: the full row for BRAVEHEART BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 70,000 shares 70,000 $1.41M 0.09% new Timeline RACC RESEARCH ALLIANCE CORP III More: the full row for RESEARCH ALLIANCE CORP III Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 370,000 shares; 2026Q3: 125,000 shares 125,000 $1.35M 0.09% -245,000 Timeline ARQT ARCUTIS BIOTHERAPEUTICS INC More: the full row for ARCUTIS BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,825,000 shares; 2025Q1: 1,350,000 shares; 2025Q2: 1,000,000 shares; 2025Q3: 775,000 shares; 2025Q4: 500,000 shares; 2026Q1: 450,000 shares; 2026Q2: 175,000 shares; 2026Q3: 50,000 shares 50,000 $1.32M 0.09% -125,000 Timeline ARWR ARROWHEAD PHARMACEUTICALS IN More: the full row for ARROWHEAD PHARMACEUTICALS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 100,000 shares; 2026Q2: 50,000 shares; 2026Q3: 15,000 shares 15,000 $982K 0.07% -35,000 Timeline COGT COGENT BIOSCIENCES INC More: the full row for COGENT BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 225,000 shares; 2026Q1: 200,000 shares; 2026Q2: 100,000 shares; 2026Q3: 30,000 shares 30,000 $961K 0.06% -70,000 Timeline GPCR STRUCTURE THERAPEUTICS INC More: the full row for STRUCTURE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 175,000 shares; 2026Q2: 75,000 shares; 2026Q3: 30,000 shares 30,000 $938K 0.06% -45,000 Timeline PCVX VAXCYTE INC More: the full row for VAXCYTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 425,000 shares; 2025Q1: 175,000 shares; 2025Q2: 175,000 shares; 2025Q3: 175,000 shares; 2025Q4: 125,000 shares; 2026Q1: 100,000 shares; 2026Q2: 50,000 shares; 2026Q3: 15,000 shares 15,000 $854K 0.06% -35,000 Timeline IRLA QUINCE THERAPEUTICS INC More: the full row for QUINCE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 5,498 shares; 2026Q3: 5,498 shares 5,498 $170K 0.01% 0 Timeline